MedPath

Survey on return to work, quality of life and long-term survival in patients with thyroid cancerLong-term survival in patients with thyroid carcinoma (ALSi) - a multicenter prospective study.

Conditions
C73
Malignant neoplasm of thyroid gland
Registration Number
DRKS00027829
Lead Sponsor
Klinik für Nuklearmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Thyroid cancer patients (ICD-10 diagnosis C73): differentiated carcinomas (papillary and follicular, including rare variants) and medullary carcinomas.
-Age at initial or recurrent diagnosis between 18 and 63 years.

Exclusion Criteria

anaplastic carcinomas and poorly differentiated carcinomas of the thyroid gland

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- How many patients actually find their way back into working life? And within what period of time after the end of therapy?
Secondary Outcome Measures
NameTimeMethod
-How many patients who have resumed work after the end of therapy also remain in work? <br>- And how do they describe the content-related, temporal and financial parameters of the resumed work? <br>- How do the patients themselves assess their prognosis for a full return to work?
© Copyright 2025. All Rights Reserved by MedPath